Showing results (201-210 of 266) with videos related to

Sort By:
Pageof 27
Dermatology Practical & Conceptual|August 12, 2025
Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic BenefitsEdoardo Cammarata, Chiara Airoldi, Jacopo Colombo, et al.
The Journal of Investigative Dermatology|November 9, 2020
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary SyndromePietro Quaglino, Paolo Fava, Alessandro Pileri, et al.
Psoriasis (Auckland, N.Z.)|August 12, 2025
Effectiveness and Safety of Tildrakizumab in Elderly and Frail Elderly Psoriatic Patients Up to 2 yearsLuca Mastorino, Paolo Dapavo, Martina Burlando, et al.
Italian Journal of Dermatology and Venereology|October 3, 2025
Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter studyMichela Starace, Stephano Cedirian, Luca Rapparini, et al.
International Journal of Dermatology|January 5, 2024
Multi-failure psoriasis patients: characterization of the patients and response to biological therapy in a multicenter Italian cohortRiccardo Viola, Luca Mastorino, Matteo Megna, et al.
Acta Dermato-Venereologica|October 3, 2025
Safety and Effectiveness Profile of Dupilumab in the Treatment of Atopic Dermatitis in Special PopulationsNiccolo Gori, Alvise Sernicola, Elena Ippoliti, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 9, 2026
Age-specific melanoma risk associated with nevi: a pooled analysis from the M-SKIP projectGiulia Doi, Aurora Gaeta, Simone Ribero, et al.
Pageof 27